MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2
2020 · Molecular Therapy — Methods & Clinical Development · 23 citations
https://doi.org/10.1016/j.omtm.2020.09.013
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Mengjing Zhu is an academic researcher.
ORCID: 0000-0003-1905-1839Click to start Chat